Terin Blanchard
Family Medicine · Macon, GANPI 1508150863
Payments from drug & device makers
Across 92 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$342
- AstraZeneca$201
- Astellas Pharma US Inc$198
- Amgen$155
- Johnson & Johnson$155
- Sanofi-aventis U.S. LLC$89
- plus $438 from 12 others
What the payments were for
- Food & beverage$1,46993%
- Education$1097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $342 |
| AstraZeneca | 14 | $201 |
| Astellas Pharma US Inc | 7 | $198 |
| Amgen | 10 | $155 |
| Johnson & Johnson | 8 | $155 |
| Sanofi-aventis U.S. LLC | 6 | $89 |
| Novartis | 4 | $65 |
| Pfizer | 3 | $62 |
| Boehringer Ingelheim | 3 | $51 |
| Lilly USA, LLC | 4 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| GSK | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Merck | 2 | $24 |
| Abbott | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
How this compares
$1,578 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 131 | $147,203 |
| OzempicSemaglutide | 78 | $127,215 |
| EliquisApixaban | 93 | $67,403 |
| TrulicityDulaglutide | 47 | $57,471 |
| XareltoRivaroxaban | 35 | $39,374 |
| JanuviaSitagliptin Phosphate | 31 | $39,329 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $37,451 |
| FarxigaDapagliflozin Propanediol | 39 | $26,891 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $18,601 |
| MyrbetriqMirabegron | 17 | $13,530 |
| TradjentaLinagliptin | 17 | $10,837 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $9,989 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 63 | $9,689 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $9,232 |
| OxycontinOxycodone Hcl | 23 | $9,153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $51 | $167,167162 claims |
| Novo NordiskOzempic | $342 | $127,21578 claims |
| PfizerEliquis | $62 | $67,40393 claims |
| Lilly USA, LLCTrulicity | $50 | $57,47147 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $35 | $51,54178 claims |
| MerckJanuvia, Belsomra | $24 | $44,62343 claims |
| Johnson & JohnsonXarelto | $155 | $39,37435 claims |
| AstraZenecaFarxiga | $201 | $26,89139 claims |
| Astellas Pharma US IncMyrbetriq | $198 | $13,53017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Macon
- Frederick BurtonMacon$66K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.